Anti-MDA5 Antibody-positive Dermatomyositis Complicated by Autoimmune-associated Hemophagocytic Syndrome That Was Successfully Treated with Immunosuppressive Therapy and Plasmapheresis-Reference-Cited by-同舟云学术

Anti-MDA5 Antibody-positive Dermatomyositis Complicated by Autoimmune-associated Hemophagocytic Syndrome That Was Successfully Treated with Immunosuppressive Therapy and Plasmapheresis

Published:2018-12-01 Issue:23 Volume:57 Page:3473-3478
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Fujita Yuya¹,Fukui Shoichi¹²,Suzuki Takahisa³,Ishida Midori¹,Endo Yushiro¹,Tsuji Sousuke¹,Takatani Ayuko¹,Igawa Takashi¹,Shimizu Toshimasa¹,Umeda Masataka¹⁴,Sumiyoshi Remi¹,Nishino Ayako¹⁵,Koga Tomohiro¹⁶,Kawashiri Shin-ya¹²,Iwamoto Naoki¹,Ichinose Kunihiro¹,Tamai Mami¹,Nakamura Hideki¹,Origuchi Tomoki¹⁷,Abe Kuniko⁸,Kawakami Atsushi¹

Affiliation:

1. Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Japan

2. Department of Community Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan

3. Department of Rheumatology, Japanese Red Cross Nagasaki Genbaku Hospital, Japan

4. Medical Education Development Center, Nagasaki University Hospital, Japan

5. Center for Comprehensive Community Care Education Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan

6. Center for Bioinformatics and Molecular Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan

7. Department of Rehabilitation Sciences, Nagasaki University Graduate School of Biomedical Sciences, Japan

8. Department of Pathology, Nagasaki University Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/57/23/57_1121-18/_pdf

Reference16 articles.

1. 1. Iaccarino L, Ghirardello A, Bettio S, et al. The clinical features, diagnosis and classification of dermatomyositis. J Autoimmun 48-49: 122-127, 2014.

2. 2. Sato S, Hirakata M, Kuwana M, et al. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum 52: 1571-1576, 2005.

3. 3. Nakashima R, Imura Y, Kobayashi S, et al. The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody. Rheumatology (Oxford) 49: 433-440, 2010.

4. 4. Gono T, Kawaguchi Y, Ozeki E, et al. Serum ferritin correlates with activity of anti-MDA5 antibody-associated acute interstitial lung disease as a complication of dermatomyositis. Mod Rheumatol 21: 223-227, 2011.

5. 5. Emile JF, Abla O, Fraitag S, et al. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood 127: 2672-2681, 2016.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hemophagocytic Lymphohistiocytosis for the Inpatient Dermatologist;Current Dermatology Reports;2024-07-12

2. Novel Therapeutic Approaches in Connective Tissue Disease-Associated Interstitial Lung Disease;Seminars in Respiratory and Critical Care Medicine;2024-05-13

3. Clinical Outcomes With and Without Plasma Exchange in the Treatment of Rapidly Progressive Interstitial Lung Disease Associated With Idiopathic Inflammatory Myopathy;JCR: Journal of Clinical Rheumatology;2022-12-07

4. Therapeutic plasma exchange for steroid refractory idiopathic inflammatory myopathies with interstitial lung disease;Journal of Clinical Apheresis;2022-11-21

5. Rare complications of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: Time to nip them in the bud;Frontiers in Immunology;2022-10-06